{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Cybin Inc."},"Symbol":{"label":"Symbol","value":"CYBN"},"Address":{"label":"Address","value":"100 KING STREET WEST,SUITE 5600, TORONTO, Ontario, M5X 1C9, Canada"},"Phone":{"label":"Phone","value":"+1 908 764-8385"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders, all protected under its ever-growing IP portfolio."},"CompanyUrl":{"label":"Company Url","value":"https://www.cybin.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Aaron Bartlone","title":"Chief Operating Officer"},{"name":"Alex Nivorozhkin","title":"Chief Scientific Officer"},{"name":"Allison House-Gecewicz","title":"Senior Vice President-Clinical Operations"},{"name":"Amir Inamdar","title":"Chief Medical Officer"},{"name":"Atul R. Mahableshwarkar","title":"Senior Vice President-Clinical Development"},{"name":"Douglas L. Drysdale","title":"Chief Executive Officer"},{"name":"Geoff Varty","title":"Head-Research & Development"},{"name":"Liz Galic","title":"Operations Director"},{"name":"Ryan Richardson","title":"Director-Information Technology"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}